The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitals

• Verfasst von: Hinderer, Marc [VerfasserIn]
• Verfasst von: Ückert, Frank [VerfasserIn]
• Verfasst von: Neumaier, Michael [VerfasserIn]
• Titel: The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitals
• Verf.angabe: Marc Hinderer, Martin Boeker, Sebastian A Wagner, Harald Binder, Frank Ückert, Stephanie Newe, Jan L Hülsemann, Michael Neumaier, Carmen Schade-Brittinger, Till Acker, Hans-Ulrich Prokosch & Brita Sedlmayr
• E-Jahr: 2017
• Jahr: June 2017
• Umfang: 13 S.
• Fussnoten: Published online 8 June 2017 ; Gesehen am 13.06.2018
• Titel Quelle: Enthalten in: Pharmacogenomics
• Ort Quelle: London : Taylor & Francis, 2000
• Jahr Quelle: 2017
• Band/Heft Quelle: 18(2017), 8, Seite 773-785
• ISSN Quelle: 1744-8042
• DOI: doi:10.2217/pgs-2017-0027
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1576308170

Abstract

Aim: The aim of this study was to assess the physicians’ attitude, their knowledge and their experience in pharmacogenomic clinical decision support in German hospitals. Materials & methods: We conducted an online survey to address physicians of 13 different medical specialties across eight German university hospitals. In total, 564 returned questionnaires were analyzed. Results: The remaining knowledge gap, the uncertainty of test reimbursement and the physicians’ lack of awareness of existing pharmacogenomic clinical decision support systems (CDSS) are the major barriers for implementing pharmacogenomic CDSS into German hospitals. Furthermore, pharmacogenomic CDSS are most effective in the form of real-time decision support for internists. Conclusion: Physicians in German hospitals require additional education of both genetics and pharmacogenomics. They need to be provided with access to relevant pharmacogenomic CDSS.